Vaginal Estrogen Warning Removed: What Women Need to Know
From Coach Marla Guloien, BCRPA-certified trainer and founder of POWER OF 30.
After more than two decades of confusion, the FDA has removed the boxed warning on vaginal estrogen products.
The short answer: the risks linked to systemic hormone therapy do not apply to low-dose vaginal estrogen, so women can seek relief without the fear.
I talked about it on the OMG Podcast with Dr. Rahi, founder of The Aesthetic Room in Beverly Hills and a leading voice in regenerative medicine. Her mission is simple: help women thrive, not just survive.
In this post
Why was there a boxed warning on vaginal estrogen?
What does the FDA decision mean today?
Why does vaginal estrogen matter for women's health?
How do you start the conversation with your doctor?
Why was there a boxed warning on vaginal estrogen?
In 2002, the Women's Health Initiative study linked systemic hormone therapy to higher risks of breast cancer, heart disease, stroke and blood clots.
The FDA then added a boxed warning to all estrogen products. That included vaginal estrogen, which is used locally for dryness, itching and painful intercourse.
The data did not match the label
The WHI data focused on systemic therapy taken orally or through the skin. Not the low-dose local products applied directly. The warning applied anyway.
Women stopped or avoided treatment. Providers hesitated to prescribe. Symptoms went untreated, and quality of life suffered.
What does the FDA decision mean today?
The decision is based on extensive research showing that vaginal estrogen:
Does not increase the risk of breast cancer or cardiovascular disease.
Is safe for long-term use in most women.
Effectively treats vulvovaginal atrophy, a common condition after menopause.
This change empowers women and their providers to make informed decisions without fear. It also encourages treatment that improves vaginal health, sexual function and overall well-being.
Why you'll love it: it helps you feel strong and in charge of your body through every stage of menopause.
Why does vaginal estrogen matter for women's health?
Vulvovaginal atrophy affects up to 50% of postmenopausal women. Symptoms include dryness, irritation, burning and pain during sex.
It can lead to discomfort, less intimacy and emotional distress. Too many women suffer in silence.
How it works
Vaginal estrogen restores the vaginal lining, improves elasticity and increases natural lubrication.
It delivers the hormone right where it is needed, with minimal absorption into the bloodstream. That localized approach reduces risks and maximizes benefits.
Why it reaches beyond comfort
Better vaginal health supports sexual function, emotional well-being and relationship satisfaction. Treating vulvovaginal atrophy can also help prevent urinary tract infections and vaginal injuries.
"Optimal hormones don't just change how you look. They change how you feel, think, and age." - Dr. Rahi
How do you start the conversation with your doctor?
If you have dryness, itching or discomfort, ask your provider whether local estrogen is right for you. Go in prepared:
Describe your symptoms and how they affect your daily life.
Ask about benefits and risks compared to other treatments.
Share your history, including any breast cancer or cardiovascular concerns.
Learn the forms: creams, tablets or rings.
Follow your provider's instructions and keep up with check-ups.
On the episode, Dr. Rahi and I also covered systemic versus local estrogen and why hormone optimization is about longevity, not vanity. Read more about her in Dr. Rahi on The Treatment.
Where strength comes in
This is a cultural shift as much as a medical one. Menopause is not the end of vitality. It is a powerful new chapter.
My part of that chapter is strength. POWER OF 30 gives you 30-minute strength sessions over 30 days, each with a warm-up, a strength block and a cool-down. Strength training is widely recommended for women in midlife, and it is something you can start on your own terms.
Key takeaways
The FDA removed the boxed warning after research separated low-dose local products from systemic therapy.
Local estrogen works where it is needed, with minimal absorption into the bloodstream.
Vulvovaginal atrophy is common after menopause and treatable.
Talk to your provider about your symptoms, history and options.
This post is for education only. It is not a substitute for individualized medical advice, diagnosis or treatment. Talk to your healthcare provider about your situation.
Comments